EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role of cuproptosis in breast cancer: Molecular mechanisms and therapeutic implications

Ke Zhang, Xiao-Han Zhang, Xue-Chun Qu, Jing Zhang, Jia-Feng Li, Pei-Hao Sun, Ruo-Yu Xu, Wei-Rong Si, Qi-Ying Jiang, Dong-Dong Wu

Apoptosis · 2026-12 · 31 (12)

DOI: 10.1007/s10495-026-02456-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Apoptosis, online erschienen am 14.11.2026. Verfasst von Ke Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, School of Stomatology, Henan University, Kaife…. Hauptthemen laut MEDLINE: Cuproptosis, Breast Neoplasms, Copper, Apoptosis. Die Arbeit nennt 162 Literaturangaben. Gefördert von: the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cuproptosis is copper-induced programmed cell death closely linked to malignant tumor phenotypes. This review summarizes the mitochondrial metabolic dysregulation-mediated mechanisms of cuproptosis and its differential regulatory networks across various breast cancer subtypes, focusing on key molecular events such as copper transport, ferredoxin 1, protein aggregation, and disruption of iron‑sulfur clusters. It systematically elaborates cuproptosis-targeted translational strategies for breast cancer. These strategies include nanodelivery systems, combination therapies with radiotherapy/chemotherapy or immunotherapy, small-molecule interventions, and approaches based on natural products. For instance, polyacrylic acid‑modified copper‑manganese‑selenium nanoplatforms achieve synergistic triple‑modal antitumor effects via chemotherapy, cuproptosis activation, and chemodynamic therapy. It highlights the prognostic value of cuproptosis-related coding genes and lncRNAs, and multi-cell-death models integrating cuproptosis, ferroptosis and pyroptosis for risk stratification and drug-resistance prediction. This article stresses breast cancer subtype heterogeneity and the tumor‑microenvironment‑driven resistance to cuproptosis therapy. It also provides new insights into how copper ion therapy reshapes the tumor immune microenvironment and mediates multidrug resistance. Furthermore, it highlights key translational challenges: the lack of cuproptosis‑specific biomarkers, inconsistent bioinformatic‑functional results, and insufficient clinical evidence for copper‑based therapeutics. Finally, the article proposes that future efforts should focus on functional validation, elucidation of signaling pathways, subtype-based therapies, and multicenter verification.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CuproptosisBreast NeoplasmsCopperApoptosisHumansFemaleTumor MicroenvironmentMitochondriaAnimals

Stichwörter der Autor:innen

Breast cancerCuproptosisPrognosis predictionSubtype-specificTreatment strategy

Substanzen

Copper

Autor:innen und Institutionen

  • Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, School of Stomatology, Henan University, Kaifeng, 475004, Henan, China.
  • School of Basic Medical Sciences, Henan University, Kaifeng, 475004, Henan, China. 10190131@vip.henu.edu.cn.
  • Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, School of Stomatology, Henan University, Kaifeng, 475004, Henan, China. jiangqiying365@126.com.
  • School of Basic Medical Sciences, Henan University, Kaifeng, 475004, Henan, China. jiangqiying365@126.com.
  • Henan International Joint Laboratory for Nuclear Protein Regulation, School of Basic Medical Sciences, School of Stomatology, Henan University, Kaifeng, 475004, Henan, China. ddwubiomed2010@163.com.
  • Department of Stomatology, Huaihe Hospital of Henan University, School of Stomatology, Henan University, Kaifeng, 475004, Henan, China. ddwubiomed2010@163.com.

Förderung

  • the National Natural Science Foundation of China

Zitieren

APA

Zhang, K., Zhang, X. H., Qu, X. C., Zhang, J., Li, J. F., Sun, P. H., Xu, R. Y., Si, W. R., Jiang, Q. Y., & Wu, D. D. (2026). The role of cuproptosis in breast cancer: Molecular mechanisms and therapeutic implications. Apoptosis, 31(12). https://doi.org/10.1007/s10495-026-02456-2

Vancouver

Zhang K, Zhang XH, Qu XC, Zhang J, Li JF, Sun PH, et al. The role of cuproptosis in breast cancer: Molecular mechanisms and therapeutic implications. Apoptosis. 2026;31(12). doi:10.1007/s10495-026-02456-2

BibTeX
@article{Zhang2026,
  author = {Zhang, Ke and Zhang, Xiao-Han and Qu, Xue-Chun and Zhang, Jing and Li, Jia-Feng and Sun, Pei-Hao and Xu, Ruo-Yu and Si, Wei-Rong and Jiang, Qi-Ying and Wu, Dong-Dong},
  title = {The role of cuproptosis in breast cancer: Molecular mechanisms and therapeutic implications},
  journal = {Apoptosis},
  year = {2026},
  volume = {31},
  number = {12},
  doi = {10.1007/s10495-026-02456-2}
}
Kostenlos starten →